Contact Molecules for Homologous Proteins | ||||
![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
879723 | 359 | 500 | P30556(AGTR1_HUMAN) | RecName: Full=Type-1 angiotensin II receptor ;AltName: Full=AT1AR ;AltName: Full=AT1BR;AltName: Full=Angiotensin II type-1 receptor ; Short=AT1 receptor ; |
QUERYSEQ |
MILNSSTEDGIKRIQDDCPKAGRHNYIFVMIPTLYSIIFVVGIFGNSLVVIVIYFYMKLKTVASVFLLNLALADLCFLLTLPLWAVYTAMEYRWPFGNYLCKIASASVSFNLYASVFLLTCLSIDRYLAIVHPMKSRLRRTMLVAKVTCI IIWLLAGLASLPAIIHRNVFFIENTNITVCAFHYESQNSTLPIGLGLTKNILGFLFPFLIILTSYTLIWKALKKAYEIQKNKPRNDDIFKIIMAIVLFFFFSWIPHQIFTFLDVLIQLGIIRDCRIADIVDTAMPITICIAYFNNCLNPL FYGFLGKKFKRYFLQLLKYIPPKAKSHSNLSTKMSTLSYRPSDNVSSSTKKPAPCFEVE |
359 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() |
1-359 | CHAIN | /note="Type-1 angiotensin II receptor" /id="PRO_0000069153" |
![]() ![]() |
1-25 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
26-55 | TRANSMEM | /note="Helical; Name=1" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
56-61 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
62-89 | TRANSMEM | /note="Helical; Name=2" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
90-98 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
99-125 | TRANSMEM | /note="Helical; Name=3" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
126-141 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
142-165 | TRANSMEM | /note="Helical; Name=4" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
166-190 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
191-216 | TRANSMEM | /note="Helical; Name=5" ECO:0000269|PubMed:26420482, ECO:0000269|PubMed:30639100, ECO:0000269|PubMed:32079768, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0, ECO:0007744|PDB:6OS1, ECO:0007744|PDB:6OS2" |
![]() ![]() ![]() |
217-239 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" |
![]() ![]() ![]() |
240-268 | TRANSMEM | /note="Helical; Name=6" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" |
![]() ![]() ![]() |
269-278 | TOPO_DOM | /note="Extracellular" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" |
![]() ![]() ![]() |
279-304 | TRANSMEM | /note="Helical; Name=7" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" |
![]() ![]() |
305-359 | TOPO_DOM | /note="Cytoplasmic" ECO:0000269|PubMed:26420482, ECO:0007744|PDB:4YAY, ECO:0007744|PDB:4ZUD" |
![]() ![]() |
335-359 | REGION | /note="Disordered" |
![]() ![]() ![]() |
335-351 | COMPBIAS | /note="Polar residues" |
![]() ![]() ![]() |
15-15 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0007744|PDB:6DO1" |
![]() ![]() ![]() |
17-17 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" |
![]() ![]() ![]() |
167-167 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" |
![]() ![]() ![]() |
182-182 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" |
![]() ![]() ![]() |
183-183 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" |
![]() ![]() ![]() |
184-184 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" |
![]() ![]() ![]() |
199-199 | BINDING | /ligand="angiotensin II" /ligand_id="ChEBI:CHEBI:58506" ECO:0000305|PubMed:32079768, ECO:0007744|PDB:6DO1, ECO:0007744|PDB:6OS0" |
![]() ![]() ![]() |
355-355 | LIPID | /note="S-palmitoyl cysteine" |
![]() ![]() ![]() ![]() ![]() |
1-359 | DISORDER | predicted by DISOPRED |
![]() |
|||||||
359 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.4 | Angiotensin receptor AT1R | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
359 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SAR1-AngII[8 aa] | A | 100.0 /99.4 |
23 /23 |
Angiotensin receptor AT1R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Nanobody Nb.AT110i1[58 aa] | A | 100.0 /98.7 |
3 /3 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Nanobody Nb.AT110i1[125 aa] | A | 100.0 /98.7 |
21 /21 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Angiotensin II[8 aa] | A | 52.2 /38.2 |
23 /24 |
AGTR2_HUMAN Type-2 angiotensin II receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ANGT_HUMAN Angiotensinogen[8 aa] | A | 100.0 /94.8 |
20 /26 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TRV023 peptide[8 aa] | A | 100.0 /94.8 |
16 /23 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | TRV026 peptide[8 aa] | A | 100.0 /94.8 |
20 /27 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | FabH[220 aa] | A | 21.4 /38.4 |
14 /18 |
AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | FabL[212 aa] | A | 50.0 /38.4 |
2 /5 |
AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | C562_ECOLX C562_ECOLX Soluble cytochrome b562,Soluble cytochrome b562[59.. | A | 33.3 /38.2 |
3 /4 |
AGTR2_HUMAN Type-2 angiotensin II receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | agonist peptide[17 aa] | B | 52.4 /37.6 |
21 /26 |
APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor Chimera.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Single domain antibody JN241[129 aa] | A | 26.9 /37.6 |
26 /32 |
APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor,Rubredoxin,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody 39[118 aa] | A | 34.8 /34.9 |
23 /23 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Nanobody[122 aa] | A | 55.0 /36.9 |
20 /21 |
C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody39[109 aa] | A | 60.0 /37.3 |
15 /16 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 66.7 /37.3 |
6 /13 |
OX2R_HUMAN Orexin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | a modified Guanine nucleotide-binding protein G(q).. | E | 66.7 /37.0 |
9 /19 |
Q548Y0_HUMAN Hypocretin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CID25 Fab heavy chain[211 aa] | A | 33.3 /37.0 |
9 /12 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | RARR2_HUMAN Retinoic acid receptor responder protein 2[9 aa] | B | 17.4 /36.9 |
23 /23 |
CML1_HUMAN Chemerin-like receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Sar1, Ile8-angiotensin II[8 aa] | A | 58.3 /38.4 |
12 /22 |
AGTR2_HUMAN C562_ECOLX AGTR2_HUMAN Type-2 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | Angiotensin-like peptide S1I8[8 aa] | A | 100.0 /98.7 |
26 /26 |
AGTR1_HUMAN C562_ECOLX AGTR1_HUMAN Type-1 angiotensin II receptor,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CCL15_HUMAN CCL15(26-92)[65 aa] | E | 34.5 /36.8 |
29 /35 |
CCR1_HUMAN C-C chemokine receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 42.1 /37.6 |
19 /19 |
CCR1_HUMAN C-C chemokine receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 33.3 /36.5 |
21 /21 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CCL20_HUMAN C-C motif chemokine 20[66 aa] | F | 18.8 /36.3 |
16 /25 |
CCR6_HUMAN C-C chemokine receptor type 6,C-C chemokine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.7 /35.9 |
15 /15 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptide agonist fMIFL[4 aa] | A | 33.3 /35.9 |
15 /16 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Peptide Agonist fMLF[3 aa] | A | 41.7 /35.9 |
12 /13 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | FME-LEU-PHE[3 aa] | A | 40.0 /35.7 |
10 /11 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 27.8 /35.7 |
18 /18 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | ELA_HUMAN Apelin receptor early endogenous ligand[15 aa] | D | 50.0 /35.6 |
18 /18 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 18.2 /35.6 |
11 /12 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | FME-TYR-PHE-ILE-ASN-ILE-LEU-THE-LEU[7 aa] | B | 42.1 /35.7 |
19 /21 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | HUNIN_HUMAN Humanin[15 aa] | B | 35.0 /35.7 |
20 /23 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CID24 Fab heavy chain[220 aa] | A | 14.8 /34.3 |
27 /29 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CID24 Fab light chain[211 aa] | A | 0.0 /34.3 |
6 /6 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CID25 Fab light chain[211 aa] | A | 50.0 /37.0 |
2 /2 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 46.2 /35.6 |
13 /14 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | G alpha gustducin protein[205 aa] | A | 28.6 /35.6 |
21 /21 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 41.7 /35.6 |
12 /13 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | DAMGO[5 aa] | E | 26.7 /35.3 |
15 /15 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | G subunit q (Gi1-Gq chimeric)[230 aa] | D | 41.4 /35.3 |
29 /30 |
BKRB2_HUMAN B2 bradykinin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CCL2_HUMAN C-C motif chemokine 2[69 aa] | A | 25.0 /35.3 |
20 /26 |
CCR2_HUMAN Isoform B of C-C chemokine receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 41.2 /35.3 |
17 /17 |
CCR2_HUMAN Isoform B of C-C chemokine receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 25.0 /34.1 |
24 /24 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 36.8 /35.3 |
19 /20 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PDYN_HUMAN Dynorphin[8 aa] | A | 26.3 /35.3 |
19 /20 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAZ_HUMAN Guanine nucleotide-binding protein G(z) subunit al.. | A | 27.8 /35.2 |
18 /19 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | E | 28.6 /35.2 |
21 /21 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /35.3 |
21 /22 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /35.3 |
21 /21 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562, Mu-type opioid receptor c.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 34.8 /35.1 |
23 /24 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 30.8 /35.1 |
26 /27 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Dynorphin[9 aa] | C | 17.4 /35.1 |
23 /24 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | IL8_HUMAN Interleukin-8[71 aa] | F | 13.3 /36.5 |
15 /27 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | IL8_HUMAN Interleukin-8[67 aa] | F | 0.0 /36.5 |
2 /2 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | IL8_HUMAN Interleukin-8[69 aa] | A | 11.8 /35.0 |
17 /25 |
CXCR1_HUMAN C-X-C chemokine receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Megabody 6[65 aa] | A | 11.1 /35.0 |
9 /10 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 28.6 /35.0 |
21 /21 |
CXCR1_HUMAN C-X-C chemokine receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | somatostatin-14[12 aa] | D | 7.7 /34.7 |
13 /13 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Polyphemusin analog, CXC chemokine receptor antago.. | A | 19.2 /34.7 |
26 /26 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 46.2 /29.4 |
13 /19 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 35.0 /34.7 |
20 /21 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | DAMGO[4 aa] | E | 23.1 /34.7 |
13 /13 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SDF1_HUMAN Stromal cell-derived factor 1[59 aa] | A | 20.6 /34.6 |
34 /43 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Synthetic peptide[5 aa] | E | 45.0 /35.7 |
20 /23 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Synthetic peptide[5 aa] | A | 33.3 /34.3 |
15 /17 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | FME-LEU-PHE-ILE-ILE[5 aa] | B | 31.6 /34.6 |
19 /20 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 31.6 /34.6 |
19 /19 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | B4DMD5_HUMAN Amyloid-beta A4 protein[16 aa] | B | 30.8 /34.6 |
26 /28 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | VMI2_HHV8P Viral macrophage inflammatory protein 2[70 aa] | A | 28.0 /34.5 |
25 /26 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4/Endolysin chimeric.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 38.9 /34.4 |
18 /19 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 46.7 /34.4 |
15 /16 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 36.8 /34.4 |
19 /20 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | endomorphin[5 aa] | A | 23.5 /34.4 |
17 /17 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 30.0 /34.4 |
20 /21 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | G | 47.1 /34.4 |
17 /18 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | LYS-ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE[9 aa] | A | 33.3 /34.4 |
24 /26 |
BKRB1_HUMAN B1 bradykinin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | G subunit q (Gi1-Gq chimeric)[235 aa] | A | 50.0 /34.4 |
24 /25 |
BKRB1_HUMAN B1 bradykinin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | ARG-PRO-PRO-GLY-PHE-SER-PRO-PHE-ARG[9 aa] | D | 41.7 /35.3 |
24 /24 |
BKRB2_HUMAN B2 bradykinin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Bradykinin[9 aa] | A | 40.0 /34.4 |
25 /25 |
Bradykinin receptor BK2R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 48.0 /34.4 |
25 /26 |
Bradykinin receptor BK2R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Kallidin[10 aa] | A | 35.7 /34.4 |
28 /29 |
Bradykinin receptor BK2R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 48.3 /34.4 |
29 /30 |
Bradykinin receptor BK2R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Octreotide[8 aa] | F | 5.6 /33.7 |
18 /18 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TRP-LYS-TYR-MET-VAL-QXV[6 aa] | A | 23.8 /35.3 |
21 /23 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Peptide agonist[6 aa] | A | 20.0 /34.3 |
15 /17 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 24.0 /34.3 |
25 /25 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 25.0 /34.3 |
20 /20 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /35.7 |
21 /21 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 27.3 /34.3 |
22 /22 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Synthetic peptide[8 aa] | F | 27.8 /34.3 |
18 /20 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 25.0 /34.2 |
20 /20 |
SSR4_HUMAN Somatostatin receptor type 4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Peptide agonist KGCHM07[5 aa] | A | 38.1 /32.5 |
21 /21 |
Delta opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CYN 154806[10 aa] | A | 20.0 /34.1 |
20 /23 |
SSR2_HUMAN XYNA_BACCI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 19.0 /33.5 |
21 /22 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Octreotide[7 aa] | A | 15.8 /34.1 |
19 /19 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Lanreotide[6 aa] | A | 6.7 /34.1 |
15 /15 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 30.4 /34.4 |
23 /24 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 27.3 /34.1 |
22 /23 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | G | 0.0 /34.1 |
1 /1 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | COLI_HUMAN Beta-endorphin[21 aa] | A | 17.6 /34.1 |
17 /17 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SDF1_HUMAN Stromal cell-derived factor 1[68 aa] | A | 28.6 /34.0 |
21 /30 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CID25 Fab light chain[105 aa] | A | 50.0 /34.0 |
2 /2 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CID24 Fab light chain[106 aa] | A | 0.0 /34.0 |
6 /6 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CID25 Fab heavy chain[123 aa] | A | 33.3 /34.0 |
12 /15 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | CID24 Fab heavy chain[125 aa] | A | 14.8 /34.0 |
27 /30 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Guanine nucleotide-binding protein G(q) subunit al.. | F | 38.5 /30.4 |
26 /29 |
Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Guanine nucleotide-binding protein G(q) subunit al.. | E | 54.5 /33.9 |
11 /17 |
C562_ECOLX MTLR_HUMAN Soluble cytochrome b562,Motilin receptor,Fusion ta.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Fab3949 H[219 aa] | A | 33.3 /33.8 |
3 /13 |
PAR2_HUMAN C562_ECOLX PAR2_HUMAN Proteinase-activated receptor 2,Soluble cytochrome.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Fab3949 L[213 aa] | A | 50.0 /33.8 |
2 /9 |
PAR2_HUMAN C562_ECOLX PAR2_HUMAN Proteinase-activated receptor 2,Soluble cytochrome.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | bifunctional peptide[5 aa] | A | 16.7 /34.3 |
12 /12 |
C562_ECOLX Soluble cytochrome b562,Delta-type opioid receptor.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SMS_HUMAN Somatostatin-14[14 aa] | A | 19.0 /33.1 |
21 /21 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | somatostatin-14[14 aa] | B | 17.4 /33.3 |
23 /23 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | SMS_HUMAN Somatostatin-14[14 aa] | A | 23.1 /33.5 |
26 /26 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.3 /33.5 |
19 /19 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Octreotide[8 aa] | F | 9.5 /33.0 |
21 /21 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | DPN-CYS-PHE-DTR-LYS-THR-CYS-THO[8 aa] | E | 6.2 /33.3 |
16 /16 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 23.5 /29.7 |
17 /17 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 27.8 /33.3 |
18 /19 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PNOC_HUMAN Nociceptin[14 aa] | A | 18.2 /33.1 |
22 /22 |
OPRX_HUMAN Nociceptin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 31.6 /33.1 |
19 /19 |
OPRX_HUMAN Nociceptin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody 6[86 aa] | A | 10.0 /33.1 |
10 /11 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Somatostatin-14 (SST-14)[12 aa] | E | 18.2 /33.3 |
22 /22 |
C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | SMS_HUMAN Somatostatin-14[12 aa] | A | 15.0 /33.5 |
20 /20 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | SMS_HUMAN Somatostatin-14[12 aa] | A | 10.5 /33.1 |
19 /19 |
SSR4_HUMAN Somatostatin receptor type 4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 20.0 /33.1 |
20 /21 |
SSR4_HUMAN Somatostatin receptor type 4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI3_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 30.8 /33.1 |
13 /13 |
SSR2_HUMAN OPRK_HUMAN SSR2_HUMAN Somatostatin receptor type 2,Kappa-type opioid rec.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 44.4 /34.4 |
18 /19 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | G | 40.0 /34.1 |
15 /16 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 46.7 /32.5 |
15 /15 |
OPRD_HUMAN Delta-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | DA2D_PHYBI deltorphin[8 aa] | A | 31.6 /32.5 |
19 /19 |
OPRD_HUMAN Delta-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 33.3 /32.5 |
21 /21 |
OPRD_HUMAN Delta-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CCL5_HUMAN C-C motif chemokine 5[68 aa] | A | 18.9 /33.8 |
37 /40 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CCL5_HUMAN C-C motif chemokine 5[67 aa] | C | 23.3 /32.4 |
30 /31 |
CCR5_HUMAN C-C chemokine receptor type 5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Q70145_9HIV1 Envelope glycoprotein gp160[398 aa] | C | 16.0 /32.4 |
25 /35 |
CCR5_HUMAN C-C chemokine receptor type 5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 41.2 /32.4 |
17 /17 |
CCR5_HUMAN C-C chemokine receptor type 5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 100.0 /99.4 |
20 /20 |
Angiotensin receptor AT1R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 50.0 /32.4 |
20 /26 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Gastrin Releasing Peptide PRGNHWAVGHLM(NH2)[13 aa].. | A | 45.8 /32.4 |
24 /34 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 50.0 /32.4 |
18 /24 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Bombesin[9 aa] | A | 38.9 /32.4 |
18 /28 |
A0A6D0N546_ECOLX GRPR_HUMAN Maltodextrin-binding protein,Gastrin-releasing pep.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 36.4 /32.3 |
11 /23 |
ADRB3_CANLF Beta-3 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 40.0 /31.8 |
20 /21 |
GPR17_HUMAN Uracil nucleotide/cysteinyl leukotriene receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 45.5 /32.4 |
22 /22 |
CCL3_HUMAN CCR5_HUMAN C-C motif chemokine 3,C-C chemokine receptor type .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 31.6 /33.3 |
19 /19 |
CCR5_HUMAN C-C chemokine receptor type 5 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 42.9 /33.2 |
14 /15 |
MTR1B_HUMAN Melatonin receptor type 1B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 20.0 /33.3 |
15 /17 |
C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 35.3 /33.3 |
17 /18 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 41.4 /35.6 |
29 /29 |
CX3C1_HUMAN CX3C chemokine receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 42.9 /36.9 |
21 /21 |
CML1_HUMAN Chemerin-like receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 30.8 /29.9 |
13 /16 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 26.1 /35.2 |
23 /23 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 16.7 /25.1 |
18 /18 |
EDNRB_HUMAN Endothelin receptor type B,Endothelin receptor typ.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 21.4 /31.8 |
14 /15 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 22.2 /31.8 |
18 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | CO3_HUMAN C3a anaphylatoxin[73 aa] | A | 19.0 /31.8 |
21 /26 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 33.3 /31.8 |
18 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | ALA-SER-LYS-LEU-GLY-LEU-ALA-ARG[8 aa] | B | 25.0 /31.8 |
16 /19 |
C3AR_HUMAN C3a anaphylatoxin chemotactic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 36.8 /31.8 |
19 /19 |
LT4R1_HUMAN Leukotriene B4 receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 23.1 /31.4 |
13 /22 |
C562_ECOLX 5HT7R_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | G-alpha q[213 aa] | B | 40.0 /31.3 |
20 /20 |
NMBR_HUMAN Neuromedin-B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | G-alpha q[206 aa] | A | 35.3 /31.4 |
17 /24 |
GRPR_HUMAN Gastrin-releasing peptide receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GRP[9 aa] | A | 54.5 /31.4 |
11 /23 |
GRPR_HUMAN Gastrin-releasing peptide receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | NMU_HUMAN Neuromedin-U-25[26 aa] | B | 14.3 /31.4 |
21 /24 |
NMUR2_HUMAN Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 43.8 /31.4 |
16 /16 |
NMUR2_HUMAN Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | NMB30[10 aa] | B | 3.6 /31.3 |
28 /31 |
NMBR_HUMAN Neuromedin-B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 23.5 /35.7 |
17 /17 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 10.5 /31.3 |
19 /19 |
RL3R2_HUMAN Relaxin-3 receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | INSL5_HUMAN Insulin-like peptide INSL5 A chain[20 aa] | E | 0.0 /31.3 |
2 /2 |
RL3R2_HUMAN Relaxin-3 receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | INSL5_HUMAN Insulin-like peptide INSL5 B chain[20 aa] | E | 12.5 /31.3 |
16 /18 |
RL3R2_HUMAN Relaxin-3 receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 10.0 /31.3 |
20 /20 |
RL3R2_HUMAN Relaxin-3 receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 13.0 /31.3 |
23 /24 |
NPY4R_HUMAN Neuropeptide Y receptor type 4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | PAHO_HUMAN Pancreatic hormone[36 aa] | A | 22.2 /31.3 |
27 /33 |
NPY4R_HUMAN Neuropeptide Y receptor type 4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.1 |
2 /2 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_MOUSE Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.0 |
4 /4 |
ADA2A_HUMAN A0A097J809_BPT4 ADA2B_HUMAN ADA2B_HUMAN Alpha-2A adrenergic receptor,Endolysin,Alpha-2B ad.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /36.5 |
1 /1 |
CXCR2_HUMAN C-X-C chemokine receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.6 |
1 /1 |
A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | B | 0.0 /29.0 |
1 /3 |
ACM1_HUMAN ACM1_HUMAN Muscarinic acetylcholine receptor M1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /29.8 |
1 /1 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Muscarinic ac.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /28.5 |
1 /3 |
D9IEF7_BPT4 DRD2_HUMAN DRD2_HUMAN Endolysin,D(2) dopamine receptor,D(2) dopamine rec.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /30.3 |
1 /1 |
Beta2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 25.0 /27.1 |
4 /4 |
MTR1A_HUMAN Melatonin receptor type 1A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.4 |
1 /1 |
BKRB1_HUMAN B1 bradykinin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /35.9 |
1 /1 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.6 |
1 /1 |
CCL5_HUMAN CCR5_HUMAN C-C motif chemokine 5,C-C chemokine receptor type .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /34.4 |
1 /1 |
Bradykinin receptor BK2R |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /28.6 |
1 /1 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /27.9 |
2 /2 |
Beta1-Adrenergic Receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 100.0 /35.1 |
1 /1 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /34.3 |
2 /2 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /35.7 |
1 /1 |
FPR1_HUMAN fMet-Leu-Phe receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /29.9 |
1 /1 |
ACM4_HUMAN Muscarinic acetylcholine receptor M4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /31.8 |
1 /1 |
LT4R1_HUMAN Leukotriene B4 receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 50.0 /35.6 |
2 /2 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | F | 0.0 /30.4 |
1 /1 |
Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 100.0 /33.3 |
2 /2 |
C562_ECOLX SSR2_HUMAN Soluble cytochrome b562,Somatostatin receptor type.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_RAT Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 0.0 /29.7 |
1 /1 |
GALR2_HUMAN Galanin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | B | 0.0 /34.6 |
1 /1 |
C562_ECOLX FPR2_HUMAN Soluble cytochrome b562,N-formyl peptide receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /29.9 |
1 /1 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GBB1_BOVIN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | A | 100.0 /34.1 |
1 /1 |
SSR2_HUMAN Somatostatin receptor type 2,LargeBit |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /35.6 |
1 /1 |
CX3C1_HUMAN CX3C chemokine receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | D | 0.0 /35.1 |
1 /1 |
X3CL1_HUMAN CX3C1_HUMAN Processed fractalkine,CX3C chemokine receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | B | 0.0 /31.4 |
1 /1 |
NMUR2_HUMAN Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /30.1 |
1 /1 |
C562_ECOLX 5HT4R_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 50.0 /31.4 |
2 /2 |
C562_ECOLX 5HT7R_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /31.8 |
1 /1 |
GPR17_HUMAN Uracil nucleotide/cysteinyl leukotriene receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | B | 100.0 /36.9 |
2 /3 |
CML1_HUMAN Chemerin-like receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /33.9 |
1 /1 |
C562_ECOLX MTLR_HUMAN Soluble cytochrome b562,Motilin receptor,Fusion ta.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GBB1_HUMAN Guanine nucleotide-binding protein G(I)/G(S)/G(T) .. | E | 0.0 /31.1 |
1 /1 |
TAA7F_MOUSE Trace amine-associated receptor 7f |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 27.3 /32.3 |
11 /20 |
ADRB3_CANLF Beta-3 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Engineered Guanine nucleotide-binding protein subu.. | E | 46.7 /30.7 |
15 /16 |
Q548Y0_HUMAN Hypocretin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | GNAI1_HUMAN GNAS2_HUMAN GNAS2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 50.0 /29.2 |
16 /16 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Guanine nucleotide-binding protein G(q) subunit al.. | A | 45.0 /29.3 |
20 /20 |
GALR2_HUMAN Galanin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Engineered Guanine nucleotide-binding protein G(q).. | E | 38.5 /34.4 |
13 /13 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | miniGq[213 aa] | A | 31.6 /31.9 |
19 /21 |
ACM3_HUMAN ACM3_HUMAN Muscarinic acetylcholine receptor M3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Guanine nucleotide-binding protein G(q) subunit al.. | C | 20.0 /25.9 |
20 /20 |
EDNRB_HUMAN LUCI_OPLGR Endothelin receptor type B,Oplophorus-luciferin 2-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Camelid Antibody Fragment[120 aa] | A | 35.3 /29.3 |
17 /20 |
LYS_BPT4 ADRB2_HUMAN ADRB2_HUMAN Lysozyme, Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Camelid antibody fragment Nb6B9[120 aa] | B | 36.4 /26.9 |
22 /27 |
ADRB1_MELGA Beta-1 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Camelid Antibody Fragment[120 aa] | A | 50.0 /25.8 |
12 /17 |
D9IEF7_BPT4 Lysozyme-Beta-1 adrenergic receptor chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 38.5 /30.9 |
13 /14 |
C562_ECOLX 5HT4R_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | OREX_HUMAN Orexin[10 aa] | E | 21.1 /30.7 |
19 /21 |
Q548Y0_HUMAN Hypocretin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | NPY_HUMAN Neuropeptide Y[22 aa] | A | 23.8 /30.5 |
21 /26 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 35.7 /30.5 |
14 /14 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NMU_HUMAN Neuromedin-U-25[9 aa] | F | 20.8 /30.4 |
24 /27 |
Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody 9-8[121 aa] | A | 25.0 /30.1 |
12 /12 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 35.3 /30.3 |
17 /18 |
Beta2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 27.8 /30.3 |
18 /19 |
ADRB2_HUMAN Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 20.0 /30.3 |
20 /20 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | C089 peptide[6 aa] | D | 0.0 /30.3 |
16 /16 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 31.2 /30.0 |
16 /17 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Guanine nucleotide-binding protein G(q) subunit al.. | F | 33.3 /30.2 |
24 /25 |
Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | NMS_HUMAN Neuromedin-S[12 aa] | F | 15.4 /30.2 |
26 /29 |
Neuromedin-U receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | D | 40.0 /29.6 |
15 /20 |
A0A097J809_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 33.3 /30.2 |
21 /24 |
ADRB2_HUMAN Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAS2_HUMAN Isoform Gnas-2 of Guanine nucleotide-binding prote.. | F | 50.0 /28.6 |
16 /20 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | E | 36.0 /30.1 |
25 /27 |
C562_ECOLX 5HT4R_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Nanobody60, Nb60[120 aa] | A | 18.2 /29.8 |
22 /25 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | nanobody 7[116 aa] | A | 26.1 /30.1 |
23 /23 |
US28_HCMVA G-protein coupled receptor homolog US28 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | A | 30.8 /29.6 |
13 /13 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 28.6 /29.9 |
14 /14 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A0A1W2PRJ7_HUMAN A0A1W2PP38_HUMAN GNAO_HUMAN G protein subunit alpha o1,Guanine nucleotide-bind.. | D | 30.0 /32.3 |
20 /21 |
GALR1_HUMAN Galanin receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAO_HUMAN GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | F | 35.7 /33.7 |
14 /15 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | B3KP89_HUMAN GNAO_HUMAN miniGo[215 aa] | A | 29.4 /29.9 |
17 /18 |
ACM4_HUMAN ACM4_HUMAN Muscarinic acetylcholine receptor M4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | NPY_HUMAN Neuropeptide Y[36 aa] | A | 31.4 /33.3 |
35 /42 |
NPY1R_HUMAN Neuropeptide Y receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | NPY_HUMAN Neuropeptide Y[36 aa] | D | 21.1 /29.9 |
19 /22 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 27.8 /29.9 |
18 /20 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 18.2 /29.9 |
11 /14 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | PYY_HUMAN Peptide YY(3-36)[25 aa] | E | 28.6 /29.9 |
21 /23 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | NPY_HUMAN Neuropeptide Y[29 aa] | E | 28.0 /29.9 |
25 /28 |
NPY2R_HUMAN Neuropeptide Y receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PMX53[7 aa] | A | 18.2 /29.9 |
22 /22 |
C562_ECOLX C5AR1_HUMAN Soluble cytochrome b562, C5a anaphylatoxin chemota.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | LYS_BPT4 Lysozyme[162 aa] | A | 50.0 /29.9 |
2 /7 |
ADRB2_HUMAN Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 35.7 /29.9 |
14 /14 |
ACM4_HUMAN Muscarinic acetylcholine receptor M4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | A | 26.7 /29.8 |
15 /15 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,Muscarinic ac.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Guanine nucleotide-binding protein G(11) subunit a.. | A | 32.1 /29.8 |
28 /28 |
P2RY1_HUMAN P2Y purinoceptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 38.1 /29.7 |
21 /21 |
P2Y12_HUMAN P2Y purinoceptor 12 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GALA_HUMAN Galanin[13 aa] | A | 9.1 /29.7 |
22 /22 |
GALR2_HUMAN Galanin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Engineered Guanine nucleotide-binding protein G(q).. | A | 42.9 /29.7 |
21 /21 |
GALR2_HUMAN Galanin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Engineered G protein subunit S (mini-Gs)[234 aa] | A | 17.9 /29.7 |
28 /28 |
GP174_HUMAN Probable G-protein coupled receptor 174 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GALA_HUMAN Galanin[16 aa] | A | 5.9 /29.7 |
17 /18 |
GALR1_HUMAN Galanin receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GALA_HUMAN Galanin[16 aa] | A | 0.0 /29.3 |
16 /17 |
GALR2_HUMAN Galanin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GALA_HUMAN Galanin[17 aa] | D | 11.8 /32.3 |
17 /18 |
GALR1_HUMAN Galanin receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | spexin[14 aa] | F | 21.1 /29.7 |
19 /19 |
GALR2_HUMAN Galanin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 10.5 /29.7 |
19 /19 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | CO5_HUMAN C5a anaphylatoxin[74 aa] | E | 10.3 /29.7 |
29 /34 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | C5apep peptide[6 aa] | F | 15.8 /29.7 |
19 /19 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | BM213 peptide[9 aa] | E | 10.0 /29.7 |
20 /20 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 19.0 /29.7 |
21 /21 |
C5AR1_HUMAN C5a anaphylatoxin chemotactic receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 42.9 /36.8 |
14 /14 |
CCR1_HUMAN C-C chemokine receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 22.2 /33.3 |
18 /19 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody6[133 aa] | A | 28.6 /32.0 |
14 /16 |
SUCR1_RAT Succinate receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | nanobody Nb71[122 aa] | A | 25.0 /29.6 |
20 /25 |
D9IEF7_BPT4 ADRB2_HUMAN ADRB2_HUMAN Endolysin, Beta-2 adrenergic receptor chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | A | 50.0 /29.6 |
16 /16 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GAST_HUMAN Gastrin[8 aa] | A | 21.4 /29.6 |
14 /19 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | cck-8[8 aa] | A | 21.4 /29.6 |
14 /19 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | X3CL1_HUMAN Fractalkine[68 aa] | A | 20.8 /30.1 |
24 /34 |
US28_HCMVA G-protein coupled receptor homolog US28 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNA11_HUMAN Guanine nucleotide-binding protein subunit alpha-1.. | F | 37.5 /29.5 |
16 /16 |
US28_HCMVA G-protein coupled receptor homolog US28 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 33.3 /29.5 |
21 /21 |
US28_HCMVA G-protein coupled receptor homolog US28 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | F | 37.5 /29.5 |
24 /24 |
US28_HCMVA G-protein coupled receptor homolog US28 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_HUMAN Guanine nucleotide-binding protein G(s) subunit al.. | F | 46.7 /29.4 |
15 /19 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | A | 29.4 /29.4 |
17 /17 |
ACM2_HUMAN ACM2_HUMAN Muscarinic acetylcholine receptor M2,muscarinic ac.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_RAT Guanine nucleotide-binding protein G(i) subunit al.. | E | 35.3 /28.5 |
17 /22 |
D9IEF7_BPT4 DRD2_HUMAN DRD2_HUMAN Endolysin,D(2) dopamine receptor,D(2) dopamine rec.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 22.7 /29.3 |
22 /23 |
GP183_HUMAN G-protein coupled receptor 183 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Anti-5-HT2B Fab light chain[211 aa] | A | 20.0 /29.2 |
5 /5 |
5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B,Soluble cytochrome.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Anti-5-HT2B Fab heavy chain[229 aa] | A | 13.3 /29.2 |
15 /18 |
5HT2B_HUMAN C562_ECOLX 5HT2B_HUMAN 5-hydroxytryptamine receptor 2B,Soluble cytochrome.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAS2_BOVIN Guanine nucleotide-binding protein G(s) subunit al.. | D | 40.0 /29.1 |
20 /25 |
ENLYS_BPT4 ADRB2_HUMAN Endolysin,Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Synthetic nanobody 51 (Sb51)[111 aa] | E | 5.6 /29.1 |
18 /20 |
Q548Y0_HUMAN Hypocretin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A0A3B3ITX3_HUMAN GNA11_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | B | 27.3 /29.0 |
22 /22 |
ACM1_HUMAN ACM1_HUMAN Muscarinic acetylcholine receptor M1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_BOVIN Guanine nucleotide-binding protein G(i) subunit al.. | D | 23.8 /29.0 |
21 /21 |
ADA2A_HUMAN A0A097J809_BPT4 ADA2B_HUMAN ADA2B_HUMAN Alpha-2A adrenergic receptor,Endolysin,Alpha-2B ad.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_RAT GNAS2_BOVIN Guanine nucleotide-binding protein G(i) subunit al.. | A | 40.0 /28.9 |
10 /17 |
Beta1-Adrenergic Receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI2_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 42.9 /28.6 |
14 /16 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Gastrin-17[17 aa] | E | 13.6 /28.6 |
22 /30 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAQ_HUMAN Guanine nucleotide-binding protein G(q) subunit al.. | F | 38.9 /28.6 |
18 /21 |
GASR_HUMAN Gastrin/cholecystokinin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CCKN_HUMAN Cholecystokinin-8[9 aa] | F | 18.5 /29.4 |
27 /27 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | CCK-8[9 aa] | F | 12.0 /28.6 |
25 /25 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_RAT Guanine nucleotide-binding protein G(i) subunit al.. | A | 47.1 /28.6 |
17 /17 |
Beta1-Adrenergic Receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 23.5 /27.3 |
17 /17 |
C562_ECOLX GPR20_HUMAN Soluble cytochrome b562,G-protein coupled receptor.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | heavy chain of Fab046[122 aa] | F | 20.0 /28.5 |
5 /12 |
C562_ECOLX GPR20_HUMAN Soluble cytochrome b562,G-protein coupled receptor.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | G324[229 aa] | A | 58.3 /28.3 |
12 /15 |
C562_ECOLX NK2R_HUMAN Soluble cytochrome b562,Substance-K receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | HIS-LYS-THR-ASP-SER-PHE-VAL-GLY-LEU-MET-NH2[11 aa].. | A | 0.0 /28.3 |
11 /17 |
C562_ECOLX NK2R_HUMAN Soluble cytochrome b562,Substance-K receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN GNAS2_HUMAN GNAI1_HUMAN GNAS2_HUMAN Chimera of Guanine nucleotide-binding protein G(i).. | C | 42.1 /28.3 |
19 /23 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Engineered G-alpha-q subunit[228 aa] | F | 44.4 /28.0 |
18 /18 |
Soluble cytochrome b562 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GHRL_HUMAN Ghrelin-28[15 aa] | F | 21.4 /28.0 |
14 /17 |
Soluble cytochrome b562 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 37.5 /27.3 |
16 /18 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | GNAO_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | F | 58.8 /36.3 |
17 /18 |
CCR6_HUMAN C-C chemokine receptor type 6,C-C chemokine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | A0A1W2PS82_HUMAN GNAO_HUMAN Guanine nucleotide-binding protein G(o) subunit al.. | B | 50.0 /27.9 |
14 /16 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GHRL_HUMAN Appetite-regulating hormone[16 aa] | B | 18.2 /27.9 |
22 /26 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Nanobody 6[117 aa] | A | 18.2 /36.0 |
11 /13 |
OPRK_HUMAN Kappa opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nb6[116 aa] | A | 12.5 /27.8 |
8 /9 |
alpha1A-adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Cholecystokinin-8[9 aa] | C | 19.2 /29.4 |
26 /26 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN GNAQ_HUMAN fusion protein of Guanine nucleotide-binding prote.. | C | 45.0 /27.7 |
20 /29 |
CCKAR_HUMAN Cholecystokinin receptor type A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | heavy chain of Fab046[218 aa] | C | 33.3 /27.6 |
3 /10 |
C562_ECOLX GPR20_HUMAN Soluble cytochrome b562,G-protein coupled receptor.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ARRB1_HUMAN Beta-arrestin-1[344 aa] | A | 32.1 /27.4 |
28 /42 |
ADRB1_MELGA Beta-1 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ARRB1_HUMAN Isoform 1B of Beta-arrestin-1[355 aa] | C | 6.7 /27.5 |
15 /22 |
5-hydroxytryptamine receptor 2B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Anti-5HT2BR Fab light chain[107 aa] | C | 25.0 /27.5 |
4 /4 |
5-hydroxytryptamine receptor 2B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Anti-5HT2BR Fab heavy chain[127 aa] | C | 22.2 /27.5 |
9 /9 |
5-hydroxytryptamine receptor 2B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | A | 35.0 /28.2 |
20 /20 |
MTR1A_HUMAN Melatonin receptor type 1A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 23.1 /24.5 |
13 /15 |
C562_ECOLX HCAR2_HUMAN Soluble cytochrome b562,Hydroxycarboxylic acid rec.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAS2_BOVIN Guanine nucleotide-binding protein G(s) subunit al.. | E | 35.3 /27.9 |
17 /18 |
Beta1-Adrenergic Receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | GHRL_HUMAN Ghrelin-27[12 aa] | E | 18.2 /27.3 |
22 /25 |
GHSR_HUMAN Growth hormone secretagogue receptor type 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Fab7881 Heavy Chain[218 aa] | A | 0.0 /27.0 |
8 /10 |
C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Fab7881 Light Chain[219 aa] | A | 0.0 /27.0 |
2 /2 |
C562_ECOLX GHSR_HUMAN Chimera of Soluble cytochrome b562 and Growth horm.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | THIO_ECOLI Thioredoxin 1[106 aa] | E | 0.0 /27.1 |
2 /2 |
ADRB1_MELGA Beta-1 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Guanine nucleotide-binding protein G(q) subunit al.. | F | 29.4 /26.8 |
17 /17 |
EDNRA_HUMAN LUCI_OPLGR Endothelin-1 receptor,Oplophorus-luciferin 2-monoo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | ASP-SMF-NLE-GLY-TRP-NLE-OEM-MEA-NH2 (NN9056)[9 aa].. | A | 14.8 /26.8 |
27 /27 |
CCKAR_HUMAN ENLYS_BPT4 CCKAR_HUMAN Cholecystokinin receptor type A,Endolysin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody 6M[117 aa] | A | 28.6 /26.5 |
7 /7 |
HRH2_HUMAN A0A8B8VNB6_BALMU HRH2_HUMAN Histamine H2 receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Camelid Antibody Fragment[121 aa] | A | 42.9 /33.6 |
7 /19 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Camelid antibody fragment Nb80[119 aa] | B | 34.8 /26.9 |
23 /27 |
ADRB1_MELGA Beta-1 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Camelid antibody fragment Nb80[119 aa] | A | 30.4 /26.3 |
23 /26 |
THIO_ECOLI ADRB1_MELGA Thioredoxin 1,Beta-1 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | EDN1_HUMAN Endothelin-1[21 aa] | F | 23.1 /26.8 |
26 /28 |
EDNRA_HUMAN LUCI_OPLGR Endothelin-1 receptor,Oplophorus-luciferin 2-monoo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | EDN1_HUMAN Endothelin-1[21 aa] | C | 15.4 /25.9 |
26 /28 |
EDNRB_HUMAN LUCI_OPLGR Endothelin receptor type B,Oplophorus-luciferin 2-.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | EDN1_HUMAN Endothelin-1[21 aa] | E | 12.9 /25.8 |
31 /34 |
Endothelin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TKN1_HUMAN Substance P[11 aa] | A | 100.0 /25.9 |
1 /8 |
NK1R_HUMAN Substance-P receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TKN1_HUMAN Substance P[11 aa] | A | 50.0 /25.9 |
2 /7 |
NK1R_HUMAN Substance-P receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | TKN1_HUMAN Substance P[11 aa] | A | 0.0 /25.9 |
5 /12 |
NK1R_HUMAN Substance-P receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 31.6 /27.1 |
19 /20 |
MTR1A_HUMAN Melatonin receptor type 1A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 20.0 /25.8 |
25 /27 |
Endothelin type B receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | C | 16.7 /25.6 |
18 /20 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | D | 26.3 /33.3 |
19 /19 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 15.4 /25.6 |
13 /14 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | GNAI1_HUMAN Guanine nucleotide-binding protein G(i) subunit al.. | E | 18.8 /25.6 |
16 /16 |
HCAR2_HUMAN Hydroxycarboxylic acid receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | IRL1620[14 aa] | F | 12.0 /25.1 |
25 /28 |
EDNRB_HUMAN Endothelin receptor type B,Endothelin receptor typ.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody 6[60 aa] | A | 18.2 /25.0 |
11 /12 |
NTR1_HUMAN OPRK_HUMAN NTR1_HUMAN Neurotensin receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | GNA13_HUMAN Guanine nucleotide-binding protein subunit alpha-1.. | C | 32.0 /25.0 |
25 /27 |
GPR35_HUMAN G-protein coupled receptor 35 |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
359 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ZD7
|
A | 100.0 /99.7 |
14 /14 |
C562_ECOLX AGTR1_HUMAN Soluble cytochrome b562,Type-1 angiotensin II rece.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
OLM
|
A | 100.0 /99.6 |
13 /13 |
C562_ECOLX AGTR1_HUMAN AGTR1_HUMAN Chimera protein of Soluble cytochrome b562 and Typ.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
KNT
|
A | 33.3 /40.0 |
6 /21 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ZLK
|
A | 50.0 /38.5 |
8 /18 |
CLTR1_HUMAN C562_ECOLX CLTR1_HUMAN Cysteinyl leukotriene receptor 1,Soluble cytochrom.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
8EM
|
A | 39.1 /38.6 |
23 /23 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
VFD
|
A | 52.9 /38.5 |
17 /17 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
HEZ
|
A | 0.0 /38.5 |
1 /5 |
C562_ECOLX AGTR2_HUMAN Soluble cytochrome b562,Type-2 angiotensin II rece.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
KO5
|
A | 28.6 /38.4 |
14 /19 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
ITD
|
A | 25.0 /36.2 |
12 /12 |
CXCR4_HUMAN LYS_BPT4 CXCR4_HUMAN C-X-C chemokine receptor type 4, Lysozyme Chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
8ES
|
A | 45.0 /37.6 |
20 /20 |
C562_ECOLX AGTR2_HUMAN Chimera protein of Type-2 angiotensin II receptor .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
EBX
|
A | 50.0 /38.0 |
18 /18 |
CXCR2_HUMAN Q9V2J8_PYRAB CXCR2_HUMAN C-X-C chemokine receptor type 2,GlgA glycogen synt.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
KNW
|
A | 23.5 /37.7 |
17 /22 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
IVB
|
A | 21.1 /37.3 |
19 /19 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CVV
|
A | 33.3 /36.9 |
15 /15 |
C562_ECOLX OPRK_HUMAN Soluble cytochrome b562, kappa-type opioid recepto.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
KNZ
|
A | 26.1 /37.1 |
23 /26 |
CLTR2_HUMAN C562_ECOLX CLTR2_HUMAN Cysteinyl leukotriene receptor 2,Soluble cytochrom.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
A6F
|
A | 0.0 /37.3 |
8 /14 |
OX2R_HUMAN Orexin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
A6F
|
E | 12.5 /37.0 |
8 /13 |
Q548Y0_HUMAN Hypocretin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
TAR
|
B | 80.0 /32.6 |
5 /5 |
ACM3_RAT D9IEF7_BPT4 ACM3_RAT Muscarinic acetylcholine receptor M3,Lysozyme,Musc.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
TAR
|
A | 100.0 /36.7 |
1 /4 |
CCR7_HUMAN NANA_STREE CCR7_HUMAN C-C chemokine receptor type 7,Sialidase A,C-C chem.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
JLW
|
A | 44.4 /36.7 |
9 /16 |
CCR7_HUMAN NANA_STREE CCR7_HUMAN C-C chemokine receptor type 7,Sialidase A,C-C chem.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
BF0
|
A | 0.0 /36.5 |
6 /14 |
OPRM_MOUSE LYS_BPT4 OPRM_MOUSE Mu-type opioid receptor, lysozyme chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
JDC
|
A | 33.3 /39.0 |
15 /20 |
OPRK_HUMAN LYS_BPT4 OPRK_HUMAN Kappa-type opioid receptor, Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
JDC
|
A | 38.5 /36.0 |
13 /13 |
OPRK_HUMAN Kappa opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
VPX
|
A | 40.0 /36.4 |
5 /21 |
PAR1_HUMAN LYS_BPT4 PAR1_HUMAN Proteinase-activated receptor 1, Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
VRJ
|
A | 18.2 /36.4 |
11 /18 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
2PE
|
A | 45.5 /36.4 |
11 /12 |
LT4R1_HUMAN FLAV_DESVH LT4R1_HUMAN Leukotriene B4 receptor 1,Flavodoxin,Leukotriene B.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
F7N
|
A | 21.4 /36.7 |
14 /17 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
F7N
|
A | 21.4 /36.8 |
14 /16 |
CCR2_HUMAN RUBR_CLOPA CCR2_HUMAN C-C chemokine receptor type 2,Rubredoxin,C-C chemo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
73R
|
A | 23.1 /35.9 |
13 /15 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
VT5
|
A | 64.3 /35.9 |
14 /14 |
CCR2_HUMAN D9IEF7_BPT4 CCR2_HUMAN Chimera protein of CC chemokine receptor type 2 is.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
GJ9
|
A | 33.3 /37.0 |
15 /15 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
8EH
|
A | 31.2 /37.9 |
16 /16 |
APJ_HUMAN RUBR_CLOPA APJ_HUMAN Apelin receptor, with Rubredoxin insertion |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
8EH
|
D | 46.2 /35.6 |
13 /13 |
C562_ECOLX APJ_HUMAN Soluble cytochrome b562,Apelin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
8RI
|
C | 20.0 /35.4 |
10 /10 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
KZR
|
C | 40.0 /35.4 |
15 /16 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
L0X
|
D | 29.4 /35.4 |
17 /18 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EID
|
E | 30.8 /35.3 |
13 /13 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
U9I
|
A | 27.3 /35.6 |
11 /11 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
U9I
|
A | 21.4 /35.2 |
14 /14 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
U99
|
A | 27.8 /35.2 |
18 /18 |
OPRK_HUMAN Kappa-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
EIG
|
D | 30.8 /35.1 |
13 /13 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562,Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
NG0
|
A | 30.0 /35.0 |
10 /10 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
VF1
|
A | 16.7 /34.9 |
12 /14 |
OPRM_MOUSE Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
A4R
|
A | 38.5 /34.8 |
13 /13 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
1KQ
|
A | 36.4 /34.7 |
11 /19 |
GHSR_HUMAN C562_ECOLX GHSR_HUMAN Growth hormone secretagogue receptor type 1,Solubl.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
GI9
|
A | 26.1 /34.6 |
23 /23 |
SSR2_HUMAN XYNA_NIACI SSR2_HUMAN Somatostatin receptor type 2,Endo-1,4-beta-xylanas.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
0NN
|
A | 25.0 /33.6 |
16 /16 |
C562_ECOLX OPRX_HUMAN Fusion protein of Nociceptin receptor and cytochro.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
DGV
|
A | 28.6 /33.6 |
14 /14 |
C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
8QY
|
E | 18.2 /35.3 |
11 /11 |
C562_ECOLX OPRM_MOUSE Soluble cytochrome b562, Mu-type opioid receptor c.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
8QY
|
A | 16.7 /34.4 |
12 /12 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
7V7
|
A | 41.7 /34.4 |
12 /13 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
MOI
|
A | 0.0 /34.4 |
6 /6 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
WH9
|
A | 25.0 /34.4 |
12 /12 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
FUI
|
E | 41.7 /34.3 |
12 /13 |
FPR2_HUMAN N-formyl peptide receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
I8B
|
A | 13.3 /34.2 |
15 /15 |
SSR4_HUMAN Somatostatin receptor type 4 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
79K
|
A | 40.0 /34.8 |
20 /20 |
CCR9_HUMAN C-C chemokine receptor type 9 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
WH2
|
A | 28.6 /34.1 |
14 /15 |
OPRM_HUMAN Mu-type opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
LMN
|
A | 40.0 /34.0 |
5 /5 |
ACKR3_HUMAN Atypical chemokine receptor 3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
MRV
|
A | 36.8 /34.0 |
19 /19 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN Chimera protein of C-C chemokine receptor type 5 a.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
A4X
|
A | 31.6 /33.9 |
19 /19 |
CCR5_HUMAN RUBR_CLOPA CCR5_HUMAN C-C chemokine receptor type 5,Rubredoxin,C-C chemo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
ERY
|
E | 0.0 /33.9 |
5 /20 |
C562_ECOLX MTLR_HUMAN Soluble cytochrome b562,Motilin receptor,Fusion ta.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
DGW
|
A | 25.0 /33.8 |
16 /16 |
C562_ECOLX OPRX_HUMAN Soluble cytochrome b562,Nociceptin receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
8TZ
|
A | 33.3 /33.8 |
12 /14 |
D9IEF7_BPT4 PAR2_HUMAN C562_ECOLX PAR2_HUMAN Lysozyme,Proteinase-activated receptor 2,Soluble c.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
8UN
|
A | 30.0 /33.8 |
10 /10 |
D9IEF7_BPT4 PAR2_HUMAN C562_ECOLX PAR2_HUMAN Lysozyme,Proteinase-activated receptor 2,Soluble c.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
MHA
|
A | 50.0 /33.3 |
2 /3 |
ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
EJ4
|
A | 0.0 /35.0 |
5 /12 |
OPRD_MOUSE LYS_BPT4 OPRD_MOUSE Delta-type opioid receptor, Lysozyme chimera |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T |
EJ4
|
A | 23.1 /33.3 |
13 /13 |
C562_ECOLX OPRD_HUMAN Soluble cytochrome b562, Delta-type opioid recepto.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
XTK
|
A | 0.0 /33.3 |
5 /17 |
ADRB1_MELGA BETA1 ADRENERGIC RECEPTOR |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
IUD
|
D | 23.1 /33.3 |
13 /13 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
JEV
|
A | 9.1 /31.0 |
11 /13 |
MTR1A_HUMAN Q9V2J8_PYRAB MTR1A_HUMAN chimera protein of Melatonin receptor type 1A and .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
JEV
|
A | 7.7 /30.8 |
13 /16 |
C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
JEV
|
E | 16.7 /27.1 |
12 /12 |
MTR1A_HUMAN Melatonin receptor type 1A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
JEV
|
A | 7.1 /27.5 |
14 /14 |
MTR1A_HUMAN Melatonin receptor type 1A |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
JEV
|
A | 16.7 /33.2 |
12 /12 |
MTR1B_HUMAN Melatonin receptor type 1B |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
6AT
|
A | 35.3 /33.2 |
17 /25 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12, Soluble cytochrome b562 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
9AF
|
A | 23.5 /33.1 |
17 /23 |
NPY1R_HUMAN D9IEF7_BPT4 NPY1R_HUMAN Neuropeptide Y receptor type 1,T4 Lysozyme,Neurope.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
9EU
|
A | 29.4 /32.5 |
17 /17 |
PTAFR_HUMAN ENLYS_BPT4 ENLYS_BPT4 PTAFR_HUMAN Platelet-activating factor receptor,Endolysin,Endo.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
9FI
|
A | 22.2 /32.8 |
9 /9 |
SSR2_HUMAN Somatostatin receptor type 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
H46
|
A | 21.4 /32.8 |
14 /19 |
A0A097J809_BPT4 NPY2R_HUMAN FLAV_DESVH NPY2R_HUMAN Human Neuropeptide Y Y2 Receptor fusion protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
7Y9
|
A | 20.0 /32.7 |
10 /19 |
Q9WTK1_CAVPO A0A097J792_BPT4 Q9WTK1_CAVPO LTB4 receptor,Lysozyme,LTB4 receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
0HK
|
A | 11.1 /32.6 |
9 /14 |
ACM3_RAT LYS_BPT4 ACM3_RAT Muscarinic acetylcholine receptor M3, Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
3C0
|
A | 0.0 /32.6 |
6 /11 |
ACM3_RAT D9IEF7_BPT4 ACM3_RAT Muscarinic acetylcholine receptor M3,Lysozyme,Musc.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
OWY
|
A | 22.2 /32.5 |
18 /18 |
Delta opioid receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
AZJ
|
A | 27.3 /32.4 |
11 /16 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12,Soluble cytochrome b562,P2Y pu.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
7Y5
|
A | 20.0 /32.4 |
10 /17 |
P2Y12_HUMAN C562_ECOLX P2Y12_HUMAN P2Y purinoceptor 12,Soluble cytochrome b562,P2Y pu.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
9ER
|
A | 23.5 /32.4 |
17 /17 |
PTAFR_HUMAN FLAV_DESVH PTAFR_HUMAN Platelet-activating factor receptor,Flavodoxin,Pla.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
5FW
|
A | 9.1 /26.7 |
11 /12 |
ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
5FW
|
B | 7.7 /26.9 |
13 /14 |
ADRB1_MELGA Beta-1 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
5FW
|
E | 12.5 /30.3 |
8 /8 |
ADRB2_HUMAN Beta-2 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
5FW
|
E | 9.1 /27.9 |
11 /11 |
Beta1-Adrenergic Receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
5FW
|
E | 12.5 /32.3 |
8 /12 |
ADRB3_CANLF Beta-3 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
H6U
|
E | 40.0 /32.3 |
10 /17 |
ADRB3_CANLF Beta-3 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
EI5
|
D | 33.3 /32.3 |
6 /14 |
ADRB3_CANLF Beta-3 adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
9EC
|
A | 0.0 /32.1 |
10 /15 |
ACM3_RAT D9IEF7_BPT4 D9IEF7_BPT4 ACM3_RAT Muscarinic acetylcholine receptor M3,Endolysin,End.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
H95
|
A | 16.7 /32.0 |
6 /6 |
SUCR1_RAT Succinate receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
WE9
|
A | 18.8 /31.9 |
16 /17 |
ACM3_HUMAN ACM3_HUMAN Muscarinic acetylcholine receptor M3 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
JRZ
|
A | 14.3 /31.9 |
7 /13 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
JRZ
|
A | 12.5 /31.9 |
8 /14 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
JSZ
|
A | 7.7 /31.9 |
13 /20 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor, Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
CVD
|
A | 14.3 /26.9 |
14 /15 |
ADRB1_MELGA BETA-1 ADRENERGIC RECEPTOR |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
CVD
|
A | 13.3 /31.9 |
15 /23 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
SNP
|
A | 11.1 /31.9 |
9 /15 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Fusion protein of Beta-2 adrenergic receptor and T.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
9AO
|
A | 16.7 /31.9 |
18 /20 |
NPY1R_HUMAN A0A097J792_BPT4 Neuropeptide Y receptor type 1,T4 Lysozyme |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
LTB
|
A | 30.8 /31.8 |
13 /13 |
LT4R1_HUMAN Leukotriene B4 receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
8IO
|
A | 33.3 /31.8 |
15 /15 |
LT4R1_HUMAN Leukotriene B4 receptor 1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
KKF
|
D | 22.2 /31.7 |
9 /14 |
GP183_HUMAN GP183_HUMAN G-protein coupled receptor 183,Soluble cytochrome .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
8K3
|
E | 0.0 /31.4 |
9 /13 |
C562_ECOLX 5HT7R_HUMAN Soluble cytochrome b562,5-hydroxytryptamine recept.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
IYF
|
C | 11.1 /31.3 |
9 /9 |
RL3R2_HUMAN Relaxin-3 receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
IYM
|
C | 15.4 /31.3 |
13 /15 |
RL3R2_HUMAN Relaxin-3 receptor 2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
E39
|
A | 0.0 /31.3 |
3 /9 |
Alpha2A adrenergic receptor |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
ERC
|
A | 25.0 /31.2 |
12 /21 |
ADRB2_HUMAN LYS_BPT4 ADRB2_HUMAN Fusion protein Beta-2 adrenergic receptor/Lysozyme.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
8VS
|
A | 60.0 /31.2 |
5 /16 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Chimera protein of Beta-2 adrenergic receptor and .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
M3J
|
A | 28.6 /31.2 |
7 /7 |
ADRB2_HUMAN D9IEF7_BPT4 ADRB2_HUMAN Beta-2 adrenergic receptor,Lysozyme,Beta-2 adrener.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B |
JEY
|
A | 23.1 /30.8 |
13 /16 |
MTR1A_HUMAN Q9V2J8_PYRAB MTR1A_HUMAN chimera protein of Melatonin receptor type 1A and .. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C |
JEY
|
A | 18.8 /30.8 |
16 /19 |
C562_ECOLX MTR1B_HUMAN RUBR_CLOPA MTR1B_HUMAN Soluble cytochrome b562,Melatonin receptor type 1B.. |
![]() |